The Effect of Aromatase Inhibitors on Cardiovascular Risk Factors in Women With Breast Cancer

Completed

Conditions studied: Breast Cancer

In brief

This study explores how aromatase inhibitor therapy affects risk factors for heart disease in postmenopausal women with breast cancer.

Key facts

Study ID
NCT01080170
Run by
University of Pittsburgh
People needed
20
Starts
2010-03-01
Expected to finish
2013-06-01
Last updated by the study team
2016-05-13

Who can join

Age: 60 and older, up to 75. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.